Suspensory Ligament Release Before and After: The Satisfaction Data

Introduction: What Men Are Really Looking For When They Search ‘Before and After’

Men who search for suspensory ligament release before-and-after results are rarely browsing casually. They are typically accomplished professionals in their 30s, 40s, and 50s who have quietly carried a concern for years. Before committing to a procedure that affects both body and confidence, they want visual proof and hard data.

Provider galleries offer a single, static comparison. They rarely disclose whether the image shows a flaccid or erect state, how long after surgery it was taken, which technique was used, or how the result held up over time.

This article cross-references what those photos imply against three sources: peer-reviewed satisfaction data (30 to 65 percent), referral-center complication studies, and the American Urological Association’s formal non-endorsement. A man weighing a significant personal and financial decision deserves the same due diligence he would apply to any major investment.

What ‘Before and After’ Photos Can and Cannot Show

Most published suspensory ligament release galleries document flaccid-state measurements only. This limitation is critical: published urology literature indicates the procedure increases the visible length of the penis but does not lengthen the erect penis, which is the dimension most men are actually trying to improve.

Photos also rarely disclose:

• Measurement conditions: stretched flaccid, resting flaccid, or erect
• Timeline: six weeks post-op or two years post-op
• Adjunct devices: whether a penile traction device (PTD) was used to achieve the pictured result

A photo is a single data point, not a distribution. It cannot show the 30 to 65 percent satisfaction range or the relapse cases behind it.

The Flaccid-Only Gain Problem

A review of penile elongation surgery published in Translational Andrology and Urology reports that, on average, the surgery increases flaccid penile length by 1 to 3 cm, especially with post-operative PTD use.

This distinction matters functionally: patients and partners typically judge satisfaction by erect appearance and performance, not flaccid measurement. When providers use the phrase “increased visible length,” they are describing a flaccid-state change that may not translate into functional or aesthetic improvement during intercourse.

What Happens After the Flash: Position-Dependent Erections

The ligament anchors the penis to the pubic bone. As noted in Trends in Urology & Men’s Health, the penis falls forward after ligamentolysis, meaning erections may become more dependent on position.

This is a permanent change in erectile mechanics that no static photo can convey. It is rarely disclosed in marketing materials and is absent from nearly every before-and-after comparison.

The Professional Position: Why the AUA Has Never Endorsed This Procedure

The American Urological Association states: “The AUA also considers the division of the suspensory ligament of the penis for increasing penile length in adults to be a procedure which has not been shown to be safe or efficacious.”

The Urology Care Foundation’s patient-facing guidance reinforces this: “Surgery to cut the suspensory ligament of the penis in adults is not shown to be safe or effective.”

This position is not a single outdated statement; it has been reaffirmed repeatedly through 2018. For a discerning patient, the implication is clear: no major professional urology body in the United States stands behind the safety or efficacy of this procedure, a fact typically absent from provider marketing.

The Satisfaction Data Behind the Photos

The Translational Andrology and Urology review concludes that outcomes from suspensory ligament release “have not consistently been favourable,” with patient and partner satisfaction rates ranging from 30 to 65 percent.

In practical terms, somewhere between one in three and two in three patients may be dissatisfied with an outcome a marketing photo presented as a success. Satisfaction data is a more complete measure than a photo because it accounts for function, partner perception, and long-term durability rather than a single visual snapshot.

Inside a Referral-Center Complication Study

A study of 12 men seen at a referral center after ligament release documented the following:

• Poor cosmetic appearance as the chief complaint: irregular residual fat nodules in 7 men, skin deformity and scarring in 4, and scrotalization in 4
• Reoperation required in 6 of 12 patients
• Wound complications in 6 patients
• Sexual dysfunction reported by 4 patients

The most striking finding: only 1 of the 12 men reported a subjective increase in penile length, despite undergoing a procedure marketed to deliver exactly that.

Comparing Surgical vs. Non-Surgical Satisfaction Rates

Recent Journal of Sexual Medicine data on hyaluronic acid (HA) filler girth enhancement shows a different picture. A 2025 single-center study reported 89 percent patient satisfaction with no serious adverse events. A separate filler-based cohort of 300 patients reported 91 percent “completely” or “mostly” satisfied, with mean filler retention of 90 percent at 12 months.

A comparative synthesis of enhancement literature found mild adverse events in only 11 to 14 percent of injection-based cases, compared with skin necrosis, ulcers, infections, or reoperations in roughly 53 percent of surgical cases. For patients who prioritize predictable results over a photograph, this gap is central evidence.

Why Results Vary So Widely: Technique Is Not Standardized

“Suspensory ligament release” is not one procedure. It includes ligament-only release, V-Y flap advancement, buffer or graft placement, and newer trans-scrotal approaches, each with a distinct outcome profile. Generic before-and-after marketing rarely specifies which technique produced the pictured result, which makes comparison across providers unreliable.

Case Studies Across Two Decades of Technique Evolution

A retrospective series of 42 patients treated between 1988 and 2005 reported an average gain of 3.2 cm with no major complications in that cohort. By contrast, a 2025 trans-scrotal technique study of 21 patients reported flaccid gains of 2.6 cm and stretched gains of 2.4 cm, with improved MGSIS (genital self-image) scores but no significant change in IIEF-5 erectile function scores.

Outcomes depend heavily on surgeon, era, and technique. A single photo cannot reveal which variables produced it.

The Cadaver Study Problem: Even Science Can’t Predict Outcomes

A 2024 cadaver study published in Aesthetic Plastic Surgery examined the most common technique, ligament release with a V-Y skin advancement flap, and found that outcomes “exhibit substantial variability and remain challenging to predict.” If researchers working with controlled anatomical models cannot reliably predict results, one marketing photo offers even less predictive value for an individual patient.

The Failure Modes No Before-and-After Gallery Will Reveal

Galleries display successful outcomes. This creates survivorship bias in the visual “evidence” patients rely on. The following realities are routinely omitted.

Relapse and Scar Contracture (The ‘Shrink-Back’ Effect)

Many patients in early studies experienced recurrence, resulting in penile shortening. True ligament reattachment is rare; scar tissue contracture is the more common and medically accurate driver of length loss. This is why optimal technique now involves placing a buffer where the ligament was, and why extended traction is considered mandatory. One provider protocol calls for wearing an extender 8 hours per day for a full year.

A UK provider disclosure states it plainly: penile shortening is the most common complication of ligamentolysis.

Scrotalization and Cosmetic Deformity

Scrotalization occurs when the base of the penis appears to merge visually with the scrotum because of altered anatomy. It appeared in 4 of 12 patients in the referral-center study, an outcome no marketing gallery would feature. It is difficult to reverse and can worsen self-perception rather than improve it.

Reoperation, Wound Complications, and the Burden of a Second Procedure

A 50 percent revision rate in referral-center data stands in stark contrast to a procedure marketed as a single definitive solution. Corrective surgery compounds cost, downtime, and psychological strain, yet recovery expectations presented at consultation rarely account for revision likelihood.

The Psychological Dimension: Why Satisfaction Lags Behind Measurements

Some patients achieve measurable gains yet remain dissatisfied. The data suggests this is not coincidental. A nationwide survey of 25,000 heterosexual American men found that 45 percent sought penile enlargement, and 30 percent of those met diagnostic criteria for body dysmorphic disorder.

Penile Dysmorphic Disorder and the Screening Gap

The Sexual Medicine Society of North America’s 2024 position statement holds that penile dysmorphic disorder (PDD) must be assessed prior to consideration for any penile augmentation procedure. In practice, this screening is frequently skipped.

Patients with unaddressed PDD may show objective improvement while reporting ongoing or worsening distress. This helps explain why satisfaction plateaus at 30 to 65 percent even after technically successful surgery: the outcome being measured (length) is not necessarily the outcome driving the concern.

Why Surgical Success Doesn’t Guarantee Emotional Resolution

European Association of Urology guidelines note that a subgroup of men do not achieve reasonable satisfaction or emotional adjustment after augmentation and, with certain psychopathological conditions, “will not benefit from such invasive procedures.” For detail-oriented professionals, the implication is significant: an invasive, high-complication procedure may not resolve the concern that motivated the search. A body-dysmorphia-aware approach, built on realistic goal-setting and staged, reversible options, aligns more closely with current evidence.

A Different Standard: How Non-Surgical Girth Enhancement Avoids These Specific Failure Modes

Rather than competing on flaccid-length photos, approaches can be evaluated by which documented failure modes they structurally avoid:

• No ligament disruption, eliminating position-dependent erection risk
• No V-Y flap or skin advancement, reducing scrotalization risk
• Reversibility, directly addressing regret and dissatisfaction

No Ligament Disruption, No Position-Dependent Erection Risk

HA filler-based girth enhancement does not involve cutting or altering the suspensory ligament, so the mechanical cause of position-dependent erections does not apply. At Stoller Medical Group, results are designed to look and feel natural in both flaccid and erect states, addressing the flaccid-only limitation of ligament release.

Reversibility as a Built-In Safeguard

HA-based protocols can be reversed with hyaluronidase (hylase) injections if a patient is dissatisfied. Ligament surgery offers no equivalent once ligament and scar architecture have changed. In the 2025 single-center study, only 1.2 percent of patients requested removal, compared with roughly 50 percent reoperation in surgical referral-center data. This safeguard responds directly to SMSNA and EAU concerns about irreversible procedures in patients who may not gain psychological benefit.

The Data Comparison at a Glance

These figures come from peer-reviewed literature, including Journal of Sexual Medicine studies, not internal marketing claims.

What This Means: Evaluating Any Provider’s Before-and-After Claims

Men still researching providers should ask:

1. Do the photos show a flaccid or erect state?
2. Which specific technique produced each result?
3. How long after the procedure was each photo taken?
4. Does the provider disclose satisfaction and complication data?
5. What are the reoperation and relapse/shortening rates?
6. Is psychological screening for body dysmorphia part of the consultation, per SMSNA and EAU guidance?

A provider unwilling to discuss these questions transparently should raise concern.

Understanding the Investment in a Non-Surgical, Staged Approach

Non-surgical girth enhancement at Stoller Medical Group starts at $7,500 and scales with desired results. Pricing is per syringe. Most patients begin with a minimum of 10 syringes, and the average first procedure uses 15 syringes. This structure supports staged, conservative planning rather than a single irreversible decision.

Surgical pricing often hides a larger cost. A patient facing a 50 percent reoperation likelihood is effectively budgeting for two procedures, plus extended recovery and a year of traction device compliance, without knowing it upfront.

Conclusion: Looking Past the Photo to the Data

Suspensory ligament release before-and-after photos typically show flaccid-only gains under one set of conditions. The peer-reviewed satisfaction data (30 to 65 percent) and referral-center findings (50 percent reoperation, scrotalization, position-dependent erections) tell a more complete and cautionary story. The AUA and Urology Care Foundation have not endorsed the procedure as safe or effective, a position maintained across years of review.

A body-dysmorphia-aware, non-surgical, staged, and reversible approach to girth enhancement structurally avoids the failure modes documented in surgical literature. The purpose here is not fear. It is the due-diligence standard a discerning professional should expect before any decision involving irreversible anatomical change.

Ready for an Evidence-Based Consultation?

Stoller Medical Group offers free, discreet consultations to discuss non-surgical girth enhancement grounded in the satisfaction and safety data above. The practice deliberately does not offer surgical lengthening because of its documented risk profile. Every consultation begins with physician-led evaluation, strict privacy, and realistic goal-setting, and is available at five locations: Manhattan, Long Island, and Albany in New York, plus Chadds Ford, Pennsylvania, and Eagan, Minnesota.